BioNote, Inc. (KRX:377740)
5,330.00
-130.00 (-2.38%)
At close: Mar 9, 2026
BioNote Revenue
BioNote had revenue of 29.50B KRW in the quarter ending September 30, 2025, with 11.53% growth. This brings the company's revenue in the last twelve months to 115.09B, up 15.32% year-over-year. In the year 2024, BioNote had annual revenue of 102.78B with 14.10% growth.
Revenue (ttm)
115.09B
Revenue Growth
+15.32%
P/S Ratio
4.69
Revenue / Employee
386.22M
Employees
298
Market Cap
540.26B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| T&L Co., Ltd. | 177.27B |
| Value Added Technology | 413.76B |
| Vieworks | 230.52B |
| Dongbang Medical | 111.86B |
| Shinhung | 98.94B |
| CLASSYS | 336.80B |
| EOFLOW | 3.98B |
| PCL, Inc. | 4.98B |